Antimicrobial susceptibility studyAntibiotic susceptibility profile of Xanthomonas maltophilia in vitro activity of β-lactam/β-lactamase inhibitor combinations
References (22)
- et al.
Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas
Diagn Microbiol Infect Dis
(1987) - et al.
Susceptibility of Pseudomonas (Xanthomonas) maltophilia to antimicrobial agents
Antimicrob News
(1989) Unusual nosocomial infections
Dis-A-Month
(1984)- et al.
Resistance of Xanthomonas maltophilia to antibiotics and the effect of β-lactamase inhibitors
Diagn Microbiol Infect Dis
(1989) - et al.
Pharmacokinetics at ticarcillin/clavulanate in severely burned patients
J Antimicrob Chemother
(1989) - et al.
The production and molecular properties of the zinc β-lactamase of Pseudomonas maltophilia IID 1275
Biochem J
(1985) Classification of β-lactamases: groups 2c, 2d, 2e, 3, and 4
Antimicrob Agents Chemother
(1989)- et al.
Purification of β-lactamases by affinity chromatography on phenylboronic acid-agarose
Biochem J
(1984) - et al.
Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiple drug-resistant Pseudomonas maltophilia
Antimicrob Agents Chemother
(1988) - et al.
Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination
Antimicrob Agents Chemother
(1979)
Distribution in clinical material and identification of Pseudomonas maltophilia
J Clin Pathol
(1979)
Cited by (47)
Study of nano-hydroxyapatite tagged alkaline protease isolated from Himalayan sub-alpine Forest soil bacteria and role in recalcitrant feather waste degradation
2023, International Journal of Biological MacromoleculesStenotrophomonas maltophilia: From trivial to grievous
2017, Indian Journal of Medical MicrobiologyVibrio cholerae (Cholera)
2012, Principles and Practice of Pediatric Infectious Diseases, Fourth EditionStenotrophomonas maltophilia
2012, Principles and Practice of Pediatric Infectious Diseases, Fourth EditionStenotrophomonas maltophilia: an emerging opportunist human pathogen
2009, The Lancet Infectious DiseasesCitation Excerpt :In addition, exposure to ceftazidime and cefepime is an established risk factor for the acquisition of S maltophilia infection.50,64 Cephalosporins combined with β-lactamase inhibitors, such as ceftazidime-clavulanic acid, ceftazidime-sulbactam, cefoperazone-sulbactam, and cefepime-clavulanic acid, do not seem to be active in vitro.128,132 Cephalosporins have been used in combination therapy as discussed below.10
Topoisomerases mutations and fluoroquinolone resistance in Stenotrophomonas maltophilia [2]
2004, International Journal of Antimicrobial Agents
Copyright © 1991 Published by Elsevier Inc.